CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY
Objective: to determine the level of the N-terminal fragment of brain natriuretic peptide progenitor (NT-proBNP) in patients with systemic lupus erythematous (SLE) prior to immunosuppressive therapy and its possible association with inflammatory markers, traditional risk factors (TRFs) for cardiovas...
Main Authors: | T. A. Panafidina, M. A. Sokhova, T. V. Popkova, D. S. Novikova, E. N. Aleksandrova, Yu. O. Korsakova, A. V. Volkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2017-09-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2410 |
Similar Items
-
Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic
by: E. L. Nasonov, et al.
Published: (2021-05-01) -
CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. A. Panafidina, et al.
Published: (2016-07-01) -
HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RISK FACTORS AND DIAGNOSTIC FEATURES
by: T. A. Panafidina, et al.
Published: (2018-07-01) -
Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis
by: T A Panafidina, et al.
Published: (2008-05-01) -
Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
by: T V Popkova, et al.
Published: (2008-05-01)